Introduction
============

The current incidence of breast cancer in pregnancy is approximately between 1.3 and 2.4 per 10,000 live births, which equates to 2%--3% of total breast cancers. The incidence is expected to increase as more women delay childbearing for socioeconomic reasons.[@b1-ott-8-1025] The increased vascularity and lymphatic drainage from the breast during pregnancy potentiate the metastatic spread of the cancer to the regional lymph nodes. Therefore, early detection of breast cancer is the best method of reducing morbidity and mortality from it.[@b3-ott-8-1025]

Mammography is less sensitive and specific among premenopausal women, especially during pregnancy. This is due to the increase in breast density and intense breast cellular proliferative activity in pregnancy.[@b4-ott-8-1025],[@b5-ott-8-1025] Even though the radiation risk to the fetus is insignificant, with the fetal dose estimated to be 0.05 μGy,[@b4-ott-8-1025] the radiation dose to the breast will, however, be raised, and the effects of this on this radiosensitive population cannot be ignored.[@b4-ott-8-1025] Besides, benign microcalcifications are common in pregnancy, and may resemble breast malignancy.[@b6-ott-8-1025],[@b7-ott-8-1025]

Ultrasonography can be used to differentiate between cysts and solid tumors and can help in visualization during fine-needle aspiration procedures of the breast that can aid in diagnosis. It is usually used in conjunction with mammography, especially when the mammography findings are equivocal. Several studies support the use of ultrasonography for breast cancer screening as an adjunct to mammography for high-risk women or women with dense breasts.[@b8-ott-8-1025] However, due to the fear of teratogenicity associated with mammography during pregnancy and the low detection rate of mammography on the dense breasts of pregnant women, ultrasound breast screening may be preferable during pregnancy. One study showed that sensitivity was approximately 83.3% and specificity was 65.5% for breast ultrasonography.[@b9-ott-8-1025] A previous comparative study on the sensitivity of breast sonography, mammography, and clinical breast examination (CBE) showed that breast sonography had the highest sensitivity.[@b10-ott-8-1025]

Nigeria, like other sub-Saharan African countries, does not have organized breast cancer screening programs. What is obtainable in this region is opportunistic screening. There is a preponderance of poor health-seeking behavior especially in Ebonyi State. This is mainly due to poverty, ignorance, and lack of functional health facilities. The management of breast cancer in pregnancy is difficult globally. But it is more difficult in our region, where most of the women with breast malignancy present late.[@b11-ott-8-1025] The cultural affinity for high parity and negation to abortion in our environment may make many pregnant women with breast malignancy reject chemoradiation, irrespective of the gestational age, if they know that it may terminate their pregnancy. It therefore becomes important that breast cancer screening is encouraged in our environment. Even though routine CBE is carried out on every booking antenatal clinic attendee at the study center, it is associated with low sensitivity and specificity.[@b12-ott-8-1025],[@b13-ott-8-1025] Breast sonography among booking antenatal women may be feasible in view of its ready availability in our environment as well as its high sensitivity and specificity. The findings from this study may help in policy formulation on the best ways of breast cancer screening in our environment. There was paucity of studies on this subject matter in this environment. It was in view of the aforementioned reasons that this study was embarked upon. Our study was aimed at evaluating and comparing the detection rates of breast lesions using CBE and breast ultrasonography among the study participants.

Methodology
===========

Abakaliki is the capital of Ebonyi State with an estimated population of 4.3 million according to the 2006 national census. It occupies a land mass of 5,935 square kilometers. About 75% of the population of Ebonyi State dwell in the rural areas, with farming as the major occupation.[@b14-ott-8-1025] This was a cross-sectional comparative study in which consenting booking antenatal clinic attendees were recruited for the study at the Antenatal Clinic of Federal Teaching Hospital, Abakaliki (FETHA), between March 3, 2014, and December 31, 2014. At FETHA and many other hospitals in Nigeria, CBE is routinely done for booking antenatal clinic attendees. A proforma was used to collate information on the sociodemographic characteristics of the women, their gestational age, knowledge of breast cancer and its risk factors, CBE findings, breast sonographic findings, and the histology reports of the biopsy specimens. The women had breast ultrasonography after the CBE. The Voluson 730 Pro V, a three-dimensional ultrasound produced by General Electric Medical Systems, Kretzetechnik GmbH and Co OHG, Tiefenbach, Austria, was used for the breast sonography. The power Doppler was used to check the vascularity of the breast lesions. The breast ultrasonography was done by two radiologists. There was a single blinding in which the trained research assistant doing the CBE did not know the breast sonographer's findings and vice versa. The CBE and breast ultrasonography were done for the participants at booking and repeated at 6 weeks postpartum. The main outcome measure consisted of the histology of the detected breast lesions from ultrasonography and/or CBE. Phone calls and even home visitation (for women who lost their phones) were made with the aim of reminding the women to honor their 6 weeks postpartum appointment. Fine-needle aspiration cytology (FNAC) was done on the women with suspicious breast lesions on CBE or breast ultrasonography or both and the histology of the specimen was done. The gold standard consisted of the histology results and 6 weeks postpartum repeat CBE and breast ultrasonography.

Using a breast cancer prevalent rate of 25.7%,[@b15-ott-8-1025] the minimum sample size for the study was calculated based on the formula for estimating sample size for prevalent studies described by Daniel:[@b16-ott-8-1025] $$n = \frac{Z^{2}P(1 - P)}{d^{2}}$$where *n* is the sample size, *Z* is the *z* statistics for 95% level of confidence, *P* is the expected prevalence or proportion, and *d* is the precision. With *Z*=1.96, *P*=0.257, and *d*=0.05, and adding an assumed attrition rate of 10%, the calculated sample size was 322.

Every consenting booking antenatal clinic attendee who participated in both CBE and breast ultrasonography and came for the 6 weeks follow-up was included in the study. The participants with suspicious breast lesions who had their breast biopsy and histology reports collated were also included. However, the exclusion criteria consisted of the booking antenatal clinic attendees who declined consent to participate in the study despite adequate counseling or who did not participate in both CBE and breast ultrasonography or who did not come for the 6 weeks repeat CBE and breast sonography. Similarly, participants with suspicious breast lesions who declined biopsy and histology of the specimens were also excluded. The ethical clearance for this study was obtained from the Ethics Committee of the Federal Teaching Hospital, Abakaliki.

Data analysis
=============

Data analysis was both descriptive and inferential at the 95% confidence level using the Statistical Package for the Social Sciences (SPSS) software version 17.0 (SPSS Inc., Chicago, IL, USA). Test of significance was done with chi-square test. A *P*-value of 0.05 or less was considered statistically significant.

Results
=======

A total of 320 booking antenatal women who met the inclusion criteria participated in the study. The mean booking gestational age was 24±5 weeks. [Table 1](#t1-ott-8-1025){ref-type="table"} shows the sociodemographic characteristics of the participants. Majority of the participants were between 25 and 34 years, urban dwellers, Ibos, civil servants, and had tertiary education and high parity. The awareness of and risk factors for breast malignancy are presented in [Table 2](#t2-ott-8-1025){ref-type="table"}. A total of 267 (83.4%) of the participants were aware of breast cancer. Most (69.1%) of the participants had their first childbirth at ≤24 years. More so, 18 (5.6%), 29 (9.1%), 7 (2.2%), and 60 (18.8%) of the participants had a family history of breast, ovarian, and colorectal cancers, a history of use of hormonal contraceptives, tobacco, and alcohol, respectively.

[Table 3](#t3-ott-8-1025){ref-type="table"} compares the CBE and ultrasound findings. Even though there were more findings from breast ultrasonography than from CBE, there was no statistically significant difference between them (25 versus 17; *P*-value =0.26). [Table 4](#t4-ott-8-1025){ref-type="table"} shows the dimensions of the breast lesions on CBE and ultrasonography. Breast ultrasound scan detected smaller lesions more than the CBE did. Also, the solid lesions were detected more than the cystic lesions. The histologic diagnosis of the breast lesions and its comparison with CBE and ultrasound findings are presented in [Tables 5](#t5-ott-8-1025){ref-type="table"} and [6](#t6-ott-8-1025){ref-type="table"}. Fibroadenoma accounted for the majority (28%) of the breast lesions, followed by lactating adenoma. The others were fibrocystic disease (16%), lipoma (8%), breast abscess (8%), mastitis (4%), and normal breast tissue (16%) ([Table 5](#t5-ott-8-1025){ref-type="table"}). Even though the sensitivity of breast ultrasonography (95.2%) was more than that of CBE (66.7%), there was no statistically significant difference between them (*P*\>0.05). However, the specificity, positive predictive value (PPV), and negative predictive value (NPV) were similar between CBE and breast ultrasonography ([Table 6](#t6-ott-8-1025){ref-type="table"}).

Discussion
==========

The principal findings from this study showed that 267 (83.4%) of the participants were aware of breast cancer. Even though there were more findings from breast ultrasonography than from CBE, there was no statistically significant difference between them (25 versus 17; *P*-value =0.26). Breast ultrasound scan detected smaller and cystic lesions more than did the CBE. The histology of the lesions showed 72% benign breast lesions, 12% inflammatory breast lesions, and 16% normal breast tissue. Even though the sensitivity of breast ultrasonography (95.2%) was more than that of CBE (66.7%), there was no statistically significant difference between them (*P*\>0.05). The specificity, PPV, and NPV were similar between CBE and breast ultrasonography.

The 83.4% of the antenatal clinic attendees who were aware of breast cancer in this study is similar to the 80% reported in Pakistan.[@b17-ott-8-1025] The high breast cancer awareness among the study participants may have been due to the high educational status of the majority of them. Also, this could be adduced to the majority of the study participants being urban dwellers. The absence of malignant tumors from this study may have been due to the young age of the participants (\<40 years), younger age at first childbirth, and high parity. It could also be due to the reduced number of participants with a family history of breast, colorectal, and ovarian malignancy and low prevalence of hormonal contraception and tobacco use among the participants. These protective factors have been previously reported by Okobia and Bunker.[@b18-ott-8-1025] The sensitivity of 95.2% recorded from ultrasonography in this study is similar to 90.4% and 100% reported in Taiwan and USA, respectively.[@b10-ott-8-1025],[@b19-ott-8-1025] However, it is slightly higher than the 83.3% reported from Singapore.[@b12-ott-8-1025] Also the specificity and NPV of breast ultrasonography recorded in this study are similar to those reported in USA.[@b19-ott-8-1025] However, the PPV of 19% reported by Robbins et al[@b19-ott-8-1025] is remarkably less than the 82.4% reported in this study.

The 66.7% sensitivity of CBE in this study is similar to the 69% reported from Iran,[@b20-ott-8-1025] but higher than the 33% reported from Taiwan.[@b13-ott-8-1025] However, the specificity, PPV, and NPV of CBE from this study are higher than those reported from Iran.[@b20-ott-8-1025] The absence of statistically significant difference between CBE and breast ultrasonography in this study implies that CBE is a very cost-effective method of detecting breast lesions. Therefore, in a low-resource setting like ours, CBE should be advocated for the low-risk population. However, both CBE and breast ultrasonography should be done for women with high risk of breast malignancy. Breast ultrasonography can also be used as an adjunct to CBE because it can characterize the lesion detected through CBE. Fibroadenoma and lactating adenoma were the commonest benign breast tumors in this study, which is similar to the results previously report from Spain.[@b21-ott-8-1025] However, inflammatory breast lesions (breast abscess and mastitis) accounted for 20% of the breast lesions in this study, which is much lower than the 70% reported from Spain.[@b21-ott-8-1025]

This study was strengthened by the histology of the suspicious lesions and the repeat CBE and breast ultrasonography at 6 weeks follow-up in order to enhance the validity of the findings. However, it was weakened by the hospital-based design, which may not be a true reflection of what is happening in the society.

In conclusion, the detection rates of breast lesions by both CBE and breast ultrasonography were equivalent during pregnancy and 6 weeks postpartum, making CBE a convenient and very cost-effective method of detecting breast lesions in our environment. However, both CBE and breast ultrasonography should be applied for women with high risk of breast malignancy. A community-based study on this subject matter is advocated especially in our environment that lacks organized breast cancer screening programs.
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###### 

Sociodemographic characteristics of the booking antenatal women

  Sociodemographic characteristics                         Frequency (N=320)   \%
  -------------------------------------------------------- ------------------- ------
  **Age (years)**                                                              
  20--24                                                   63                  19.7
  25--29                                                   158                 49.4
  30--34                                                   80                  25.0
  35--39                                                   19                  5.9
  **Area**                                                                     
  Rural                                                    100                 31.3
  Urban                                                    220                 68.8
  **Educational qualification**                                                
  Primary                                                  18                  5.6
  Secondary                                                141                 44.1
  Tertiary                                                 161                 50.3
  **Tribe**                                                                    
  Ibo                                                      285                 80.1
  Yoruba                                                   5                   1.6
  Hausa                                                    3                   0.9
  Others[a](#tfn1-ott-8-1025){ref-type="table-fn"}         27                  8.4
  **Occupation**                                                               
  Unemployed                                               100                 31.3
  Teaching                                                 20                  6.3
  Civil service                                            121                 37.8
  Trading                                                  38                  11.9
  Artisans                                                 20                  6.3
  Professional[b](#tfn2-ott-8-1025){ref-type="table-fn"}   21                  6.6
  **Parity**                                                                   
  0                                                        56                  17.5
  1                                                        60                  18.8
  2--4                                                     135                 42.2
  \>4                                                      69                  21.6

**Notes:**

Yala, Igala, Idoma, Ibibio;

Doctors, lawyers, pharmacists, nurses/midwives.

###### 

The awareness of and risk factors for breast malignancy

  Awareness and risk factors                                      Frequency (N=320)   \%
  --------------------------------------------------------------- ------------------- ------
  **Awareness of breast cancer**                                                      
  Yes                                                             267                 83.4
  No                                                              53                  16.6
  **Age at first childbirth**                                                         
  \<20                                                            100                 31.3
  20--24                                                          121                 37.8
  25--29                                                          58                  18.1
  30--34                                                          41                  12.8
  **History of prior use of hormonal contraceptives**                                 
  Yes                                                             29                  9.1
  No                                                              291                 90.9
  **Family history of breast, colorectal, and ovarian cancers**                       
  Yes                                                             18                  5.6
  No                                                              302                 94.4
  **Use of tobacco**                                                                  
  Yes                                                             7                   2.2
  No                                                              313                 97.8
  **Use of alcohol**                                                                  
  Yes                                                             60                  18.8
  No                                                              260                 81.3

###### 

Comparison of CBE and ultrasound findings

  Findings         N=320         
  ---------------- ------- ----- ------
  Cystic lesions   **7**   12    0.26
  Solid lesions    10      13    
  Normal           303     295   

**Abbreviation:** CBE, clinical breast examination.

###### 

The dimensions of the lesions

  Tumors           CBE   Ultrasound               
  ---------------- ----- ------------ --- --- --- ---
  Cystic lesions   1     2            4   5   3   4
  Solid lesions    3     4            3   4   6   3

**Abbreviation:** CBE, clinical breast examination.

###### 

Histologic diagnosis of the lesions[a](#tfn5-ott-8-1025){ref-type="table-fn"} and its comparison with CBE and ultrasound findings

  Tumor                 Frequency   \%
  --------------------- ----------- -----
  Fibroadenoma          7           28
  Lactating adenoma     5           20
  Fibrocystic disease   4           16
  Lipoma                2           8
  Breast abscess        2           8
  Mastitis              1           4
  Normal                4           16
  Total                 25          100

**Note:**

One of the lesions on histology was detected through CBE only, while seven were detected through ultrasound only.

**Abbreviation:** CBE, clinical breast examination.

###### 

Comparison of breast lesion detection with CBE and ultrasound

  Procedure                                              Sensitivity (%)   Specificity (%)   PPV (%)   NPV (%)   *P*-value
  ------------------------------------------------------ ----------------- ----------------- --------- --------- -----------
  CBE[a](#tfn7-ott-8-1025){ref-type="table-fn"}          66.7              99.0              82.4      97.7      \>0.05
  Ultrasound[b](#tfn8-ott-8-1025){ref-type="table-fn"}   95.2              98.7              80        99.7      

**Notes:**

Lesions, 14, normal breast tissue 3;

lesions, 20, normal breast tissue 5.

**Abbreviations:** CBE, clinical breast examination; PPV, positive predictive value; NPV, negative predictive value.
